Lack of activated Smad2 in transforming growth factor-β signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma
2003 ◽
Vol 104
(2)
◽
pp. 161-166
◽
2007 ◽
Vol 70
(6)
◽
pp. 464-469
◽
2004 ◽
Vol 108
(6)
◽
pp. 818-824
◽
1990 ◽
Vol 187
(2)
◽
pp. 263-269
◽
1999 ◽
Vol 125
(8)
◽
pp. 849
◽
2009 ◽
Vol 69
(24)
◽
pp. 9301-9305
◽